Further progress for therapeutic solutions in psoriasis

L Chu¹, M Zhang¹, Y Ran¹

Affiliations

Comment

L Chu et al. Br J Dermatol. 2017 Oct.

. 2017 Oct;177(4):896-897.

doi: 10.1111/bjd.15845.

L Chu¹, M Zhang¹, Y Ran¹

¹ Department of Dermatology, West China Hospital, Sichuan University, China, 610041.

No abstract available

Comment on

Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study.
Reich K, Pinter A, Lacour JP, Ferrandiz C, Micali G, French LE, Lomaga M, Dutronc Y, Henneges C, Wilhelm S, Hartz S, Paul C; IXORA-S investigators. Reich K, et al. Br J Dermatol. 2017 Oct;177(4):1014-1023. doi: 10.1111/bjd.15666. Epub 2017 Jul 19. Br J Dermatol. 2017. PMID: 28542874 Clinical Trial.